@article{Arabi_Y-2021_89574,
title = {Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial},
author = {Arabi, Y. and Gordon, A. and Derde, L. and Nichol, A. and Murthy, S. and Al-Beidh, F. and Annane, D. and Al-Swaidan, L. and Beane, A. and Beasley, R. and Berry, L. and Bhimani, Z. and Bonten, M. and Bradbury, C. and Brunkhorst, F. and Buxton, M. and Buzgau, A. and Cheng, A. and de Jong, M. and Detry, M. and Duffy, E. and Estcourt, L. and Fitzgerald, M. and Fowler, R. and Girard, T. and Goligher, E. and Goossens, H. and Haniffa, R. and Higgins, A. and Hills, T. and Horvat, C. and Huang, D. and King, A. and Lamontagne, F. and Lawler, P. and Lewis, R. and Linstrum, K. and Litton, E. and Lorenzi, E. and Malakouti, S. and McAuley, D. and McGlothlin, A. and Mcguinness, S. and McVerry, B. and Montgomery, S. and Morpeth, S. and Mouncey, P. and Orr, K. and Parke, R. and Parker, J. and Patanwala, A. and Rowan, K. and Santos, M. and Saunders, C. and Seymour, C. and Shankar-Hari, M. and Tong, S. and Turgeon, A. and Turner, A. and Van de Veerdonk, F. and Zarychanski, R. and Green, C. and Berry, S. and Marshall, J. and McArthur, C. and Angus, D. and Webb, S. and REMAP-CAP Investigators},
month = {jul},
year = {2021},
abstract = {PURPOSE: To study the efficacy of lopinavir-ritonavir and hydroxychloroquine in critically ill patients with coronavirus disease 2019 (COVID-19).},
pages = {867-886 },
volume = {47 },
issue = {8 },
journal = {Intensive Care Medicine},
publisher = {Springer Nature},
url = {https://doi.org/10.1007/s00134-021-06448-5},
}
